Expression and regulation of peroxiredoxin 5 in human osteoarthritis

Wang, MX;Wei, AQ;Yuan, J;Trickett, A;Murrell, GAC;et.al.
(2002) FEBS Letters — Vol. 531, n° 2, p. 359-362 (2002)

Files

PRDX5-osteoarthritisFEBS2002.pdf
  • Restricted Access
  • Adobe PDF
  • 139.35 KB
Wangal.pdf
  • Restricted Access
  • Adobe PDF
  • 139.35 KB
WangetalFEBSLetters2002.pdf
  • Restricted Access
  • Adobe PDF
  • 120.74 KB
WangetalFEBSLetters2002.pdf
  • Restricted Access
  • Adobe PDF
  • 120.74 KB
WangetalFEBSLetters2002.pdf
  • Restricted Access
  • Adobe PDF
  • 120.74 KB

Details

Authors
  • Wang, MX
    Author
  • Wei, AQ
    Author
  • Yuan, J
    Author
  • Trickett, A
    Author
  • Knoops, BernardUCLouvain
    Author
  • Murrell, GAC
    Author
Show more
Abstract
Reactive oxygen species (ROS) are implicated in the pathogenesis of osteoarthritis (OA). However, little is known about the antioxidant defence system in articular cartilage. We investigated the expression and regulation of peroxiredoxin 5 (PRDX5), a newly discovered thioredoxin peroxidase, in human normal and osteoarthritic cartilage. Our results show that human cartilage constitutively expresses PRDX5. Moreover, the expression is up-regulated in OA. Inflammatory cytokines tumour necrosis factor a and interleukin 10 contribute to this upregulation by increasing intracellular ROS production. The present study suggests that PRDX5 may play a protective role against oxidative stress in human cartilage. (C) 2002 Published by Elsevier Science B.V. on behalf of the Federation of European Biochemical Societies.
Affiliations

Citations

Wang, M., Wei, A., Yuan, J., Trickett, A., Knoops, B., & Murrell, G. (2002). Expression and regulation of peroxiredoxin 5 in human osteoarthritis. FEBS Letters, 531(2), 359-362. https://hdl.handle.net/2078.5/32193 (Original work published 2002)